Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Horm Metab Res ; 45(2): 137-46, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23143666

ABSTRACT

Treatment options for adrenocortical carcinoma (ACC) are very limited. In other solid tumors, small vaccination trials targeting the anti-apoptotic molecule survivin suggested immunological and clinical benefit in selected patients. Therefore, we investigated whether survivin might be a suitable target for immunotherapy in ACC. Survivin mRNA and protein expression was assessed in adrenal tissue specimens [by real-time-PCR in 29 ACC, 24 adrenocortical adenomas (ACA) and 12 normal adrenal glands; by immunohistochemistry in 167 ACCs, 15 ACA, and 5 normal adrenal glands]. Expression was correlated with clinical outcome using Kaplan-Meier and Cox regression analyses. The anti-apoptotic role of survivin was investigated in the SW13 ACC cell line using survivin siRNA. The presence of spontaneous survivin specific T-cells in peripheral blood was assessed by FACS dextramere staining in 29 ACC patients in comparison to healthy controls. Survivin mRNA in ACC was significantly overexpressed when compared with ACA or normal adrenal glands. Immunohistochemistry confirmed survivin protein expression in 97% of the ACCs. In 83% of samples, staining was moderate or high and clinical outcome in this subgroup showed a trend towards poorer prognosis [hazard ratio for death 2.28 (95% CI 0.99-5.28); p=0.053]. Survivin knockdown in SW-13 cell significantly increased the rate of apoptosis. Finally, spontaneous survivin-reactive T cells were detectable in 3 of 29 ACC patients. In conclusion, our data suggest that survivin could play an important role in the anti-apoptotic mechanisms in ACC and provide first hints that targeting survivin might be an interesting new therapeutic approach in this rare disease.


Subject(s)
Adrenal Cortex Neoplasms/metabolism , Adrenal Cortex/metabolism , Adrenocortical Carcinoma/metabolism , Inhibitor of Apoptosis Proteins/metabolism , Neoplasm Proteins/metabolism , Adrenal Cortex/drug effects , Adrenal Cortex/pathology , Adrenal Cortex Neoplasms/diagnosis , Adrenal Cortex Neoplasms/drug therapy , Adrenal Cortex Neoplasms/pathology , Adrenocortical Adenoma/drug therapy , Adrenocortical Adenoma/metabolism , Adrenocortical Adenoma/physiopathology , Adrenocortical Carcinoma/diagnosis , Adrenocortical Carcinoma/drug therapy , Adrenocortical Carcinoma/pathology , Adult , Aged , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Cohort Studies , Female , Follow-Up Studies , Gene Expression Regulation, Neoplastic/drug effects , Humans , Inhibitor of Apoptosis Proteins/antagonists & inhibitors , Inhibitor of Apoptosis Proteins/genetics , Male , Middle Aged , Molecular Targeted Therapy , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , Prognosis , RNA Interference , Survival Analysis , Survivin
3.
Mol Cell Biol ; 19(10): 7264-75, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10490661

ABSTRACT

The BCL-6 proto-oncogene encodes a POZ/zinc-finger transcription factor that is expressed in B cells and a subset of CD4(+) T cells within germinal centers. Recent evidence suggests that BCL-6 can act as a sequence-specific repressor of transcription, but the target genes for this activity have not yet been identified. The binding site for BCL-6 shares striking homology to the sites that are the target sequence for the interleukin-4 (IL-4)-induced Stat6 (signal transducers and activators of transcription) signaling molecule. Electrophoretic mobility shift assays demonstrate that BCL-6 can bind, with different affinities, to several DNA elements recognized by Stat6. Expression of BCL-6 can repress the IL-4-dependent induction of immunoglobulin (Ig) germ line epsilon transcripts, but does not repress the IL-4 induction of CD23 transcripts. Consistent with the role of BCL-6 in modulating transcription from the germ line epsilon promoter, BCL-6(-/-) mice display an increased ability to class switch to IgE in response to IL-4 in vitro. These animals also exhibit a multiorgan inflammatory disease characterized by the presence of a large number of IgE(+) B cells. The apparent dysregulation of IgE production is abolished in BCL-6(-/-) Stat6(-/-) mice, indicating that BCL-6 regulation of Ig class switching is dependent upon Stat6 signaling. Thus, BCL-6 can modulate the transcription of selective Stat6-dependent IL-4 responses, including IgE class switching in B cells.


Subject(s)
DNA-Binding Proteins/metabolism , Immunoglobulin Class Switching , Immunoglobulin E/genetics , Interleukin-4/pharmacology , Proto-Oncogene Proteins/metabolism , Trans-Activators/metabolism , Transcription Factors/metabolism , Animals , B-Lymphocytes/immunology , Binding Sites , Gene Expression Regulation , Germ Cells/metabolism , Mice , Mice, Knockout , Protein Binding , Proto-Oncogene Proteins c-bcl-6 , STAT6 Transcription Factor , Signal Transduction , Trans-Activators/genetics , Transcription, Genetic
4.
Biophys J ; 73(6): 3211-24, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9414232

ABSTRACT

The diffusion of hen egg-white lysozyme has been studied by dynamic light scattering in aqueous solutions of ammonium sulfate as a function of protein concentration to 30 g/liter. Experiments were conducted under the following conditions: pH 4-7 and ionic strength 0.05-5.0 M. Diffusivity data for ionic strengths up to 0.5 M were interpreted in the context of a two-body interaction model for monomers. From this analysis, two potential-of-mean-force parameters, the effective monomer charge, and the Hamaker constant were obtained. At higher ionic strength, the data were analyzed using a model that describes the diffusion coefficient of a polydisperse system of interacting protein aggregates in terms of an isodesmic, indefinite aggregation equilibrium constant. Data analysis incorporated multicomponent virial and hydrodynamic effects. The resulting equilibrium constants indicate that lysozyme does not aggregate significantly as ionic strength increases, even at salt concentrations near the point of salting-out precipitation.


Subject(s)
Muramidase/chemistry , Ammonium Sulfate , Animals , Biophysical Phenomena , Biophysics , Chickens , Diffusion , Electrolytes , Female , Hydrogen-Ion Concentration , In Vitro Techniques , Light , Macromolecular Substances , Models, Chemical , Osmolar Concentration , Scattering, Radiation , Solutions , Water
5.
J Bacteriol ; 178(5): 1457-64, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8631725

ABSTRACT

Bacterial conjugation normally involves the unidirectional transfer of DNA from donor to recipient. Occasionally, conjugation results in the transfer of DNA from recipient to donor, a phenomenon known as retrotransfer. Two distinct models have been generally considered for the mechanism of retrotransfer. In the two-way conduction model, no transfer of the conjugative plasmid is required. The establishment of a single conjugation bridge between donor and recipient is sufficient for the transfer of DNA in both directions. In the one-way conduction model, transfer of the conjugative plasmid to the recipient is required to allow the synthesis of a new conjugation bridge for the transfer of DNA from recipient to donor. We have tested these models by the construction of a mutant of the self-transmissible, IncP plasmid RK2lac that allows the establishement of the conjugation bridge but is incapable of self-transfer. Four nucleotides of the nic region of the origin of transfer (oriT) were changed directly in the 67-kb plasmid RK2lac by a simple adaptation of the vector-mediated excision (VEX) strategy for precision mutagenesis of large plasmids (E. K.Ayres, V. J. Thomson, G. Merino, D. Balderes, and D. H. Figurski, J. Mol. Biol. 230:174-185, 1993). The resulting RK2lac oriT1 mutant plasmid mobilizes IncQ or IncP oriT+ plasmids efficiently but transfers itself at a frequency which is 10(4)-fold less than that of the wild type. Whereas the wild-type RK2lac oriT+ plasmid promotes the retrotransfer of an IncQ plasmid from Escherichia coli or Pseudomonas aeruginosa recipients, the RK2lac oriT1 mutant is severely defective in retrotransfer. Therefore, retrotransfer requires prior transfer of the conjugative plasmid to the recipient. The results prove that retrotransfer occurs by two sequential DNA transfer events.


Subject(s)
Conjugation, Genetic , Escherichia coli/genetics , Plasmids/genetics , Pseudomonas aeruginosa/genetics , Base Sequence , Biological Transport , Cloning, Molecular , Models, Genetic , Molecular Sequence Data , Mutation , Plasmids/metabolism , Replication Origin
6.
J Antibiot (Tokyo) ; 45(12): 1853-66, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1490876

ABSTRACT

HPLC bioautography of the directed biosynthesis of Zalerion arboricola led to the discovery of pneumocandin B0 (L-688,786), a new antifungal and anti-Pneumocystis carinii lipopeptide. Isolation techniques were developed to separate this component from pneumocandin A0 (L-671,329) in fermentations of a mutant of Zalerion arboricola. A number of related compounds were also isolated, which differ from pneumocandins A0 and B0 in the hydroxylation patterns on the ornithine, homotyrosine, and proline.


Subject(s)
Anti-Bacterial Agents , Antifungal Agents/isolation & purification , Mitosporic Fungi/chemistry , Peptides , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Biotransformation , Candida albicans/drug effects , Chromatography, Gel , Chromatography, High Pressure Liquid , Echinocandins , Microbial Sensitivity Tests , Microbiological Techniques , Mitosporic Fungi/metabolism , Peptides, Cyclic/chemistry , Peptides, Cyclic/isolation & purification , Peptides, Cyclic/pharmacology , Pneumocystis/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...